Alzheimer's drug-development pipeline: 2016

BACKGROUND: Alzheimer's disease (AD) is growing in frequency and new therapies are urgently needed. METHODS: We assessed clinicaltrials.gov (accessed 1-4-2016) to determine the number and characteristics of trials in phase I, phase II, and phase III for treatment of AD. RESULTS: There are curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Morstorf, Travis, Lee, Garam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651348/
https://www.ncbi.nlm.nih.gov/pubmed/29067309
http://dx.doi.org/10.1016/j.trci.2016.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651348/
https://www.ncbi.nlm.nih.gov/pubmed/29067309
http://dx.doi.org/10.1016/j.trci.2016.07.001

Ejemplares similares